Assessing Outcome After H-graft Shunt Placement

Portal Hypertension Clinical Trial

— PHTN  

Official title:

A Study Assessing Patient Outcomes After Placement of H-graft Portacaval Shunts for the Treatment of Portal Hypertension

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00519610
• Other study ID #: 105982
• Status: Completed
• Phase: N/A
• First received: August 21, 2007
• Last updated: August 14, 2012
• Start date: July 2007
• Est. completion date: July 2010

Study information

• Verified date: August 2012
• Source: University of South Florida
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The objective of this study is to evaluate the pre-operative symptoms and medical history of patients with portal hypertension who have undergone placement of H-graft portacaval shunts and correlate this with patient outcomes.

Description:

Research data will be collected by accessing the Tampa General Hospital medical record charts as well as the Harbourside medical charts, and extracting the necessary research data. The charts will be reviewed for the relevant medical information in order to assess outcomes in patients having H-graft shunts placed for the treatment of portal hypertension.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: July 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients who have had H-graft shunts placed for the treatment of portal hypertension.

Exclusion Criteria:

• Patients under the age of 18 will not be included in this study.

Study Design

N/A

Related Conditions & MeSH terms

• Hypertension
• Hypertension, Portal
• Portal Hypertension

Intervention

Other:
• Chart Review
Patients' charts will be reviewed for relevant medical information.

Locations

Country	Name	City	State
United States	Tampa General Hospital/University of South Florida	Tampa	Florida

Sponsors (1)

Lead Sponsor	Collaborator
University of South Florida

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The objective of this study is to evaluate the pre-operative symptoms and medical history of patients with portal hypertension who have undergone placement of H-graft portacaval shunts and correlate this with patient outcomes.		5 years	No